Personalized Medicine May Be Good for Patients but Bad for Drug Companies …
Personalized Medicine May Be Good For Patients But Bad For Drug Companies …
A similar finding came in a 2012 report from Stanford University researchers that genetics plays a significant role in determining which patients will experience the most severe side effects of opiate pain medications such as morphine, methadone and … Read more on Forbes
Acura Pharmaceuticals (ACUR): Should Investors Contain Their Excitement?
… more than a fifth of their value (sinking 21% to $ 1.47) before trading was halted. Acura Pharmaceuticals' Aversion H&A, a treatment intended to deter drug abuse via snorting, failed to make a statistically significant breakthrough and the company … Read more on SmallCap Network